GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eisai Co Ltd (OTCPK:ESAIY) » Definitions » Cyclically Adjusted Book per Share

Eisai Co (Eisai Co) Cyclically Adjusted Book per Share : $4.09 (As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Eisai Co Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Eisai Co's adjusted book value per share for the three months ended in Mar. 2024 was $5.090. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $4.09 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Eisai Co's average Cyclically Adjusted Book Growth Rate was 7.10% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 2.30% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -4.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Eisai Co was 2.30% per year. The lowest was -11.50% per year. And the median was -9.85% per year.

As of today (2024-05-22), Eisai Co's current stock price is $10.47. Eisai Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $4.09. Eisai Co's Cyclically Adjusted PB Ratio of today is 2.56.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Eisai Co was 5.25. The lowest was 1.33. And the median was 2.80.


Eisai Co Cyclically Adjusted Book per Share Historical Data

The historical data trend for Eisai Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eisai Co Cyclically Adjusted Book per Share Chart

Eisai Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.21 20.85 17.33 4.34 4.09

Eisai Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.34 4.09 4.00 4.28 4.09

Competitive Comparison of Eisai Co's Cyclically Adjusted Book per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Eisai Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eisai Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eisai Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Eisai Co's Cyclically Adjusted PB Ratio falls into.



Eisai Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Eisai Co's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=5.09/107.2000*107.2000
=5.090

Current CPI (Mar. 2024) = 107.2000.

Eisai Co Quarterly Data

Book Value per Share CPI Adj_Book
201406 4.330 98.000 4.736
201409 4.401 98.500 4.790
201412 4.315 97.900 4.725
201503 4.353 97.900 4.767
201506 4.219 98.400 4.596
201509 4.274 98.500 4.652
201512 4.298 98.100 4.697
201603 4.441 97.900 4.863
201606 4.531 98.100 4.951
201609 4.705 98.000 5.147
201612 4.473 98.400 4.873
201703 4.524 98.100 4.944
201706 4.540 98.500 4.941
201709 4.675 98.800 5.072
201712 4.569 99.400 4.928
201803 4.888 99.200 5.282
201806 4.722 99.200 5.103
201809 4.901 99.900 5.259
201812 4.668 99.700 5.019
201903 4.932 99.700 5.303
201906 4.909 99.800 5.273
201909 4.947 100.100 5.298
201912 5.156 100.500 5.500
202003 5.494 100.300 5.872
202006 5.503 99.900 5.905
202009 5.603 99.900 6.012
202012 5.649 99.300 6.098
202103 5.629 99.900 6.040
202106 5.723 99.500 6.166
202109 5.782 100.100 6.192
202112 5.629 100.100 6.028
202203 5.507 101.100 5.839
202206 5.237 101.800 5.515
202209 5.040 103.100 5.240
202212 5.003 104.100 5.152
202303 5.217 104.400 5.357
202306 5.210 105.200 5.309
202309 5.080 106.200 5.128
202312 4.958 106.800 4.977
202403 5.090 107.200 5.090

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Eisai Co  (OTCPK:ESAIY) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Eisai Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=10.47/4.09
=2.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Eisai Co was 5.25. The lowest was 1.33. And the median was 2.80.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Eisai Co Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Eisai Co's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Eisai Co (Eisai Co) Business Description

Industry
Traded in Other Exchanges
Address
4-6-10 Koishikawa, Bunkyo-ku, Tokyo, JPN, 112-8088
Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of a pharmaceutical business and other businesses. The pharmaceutical business is categorized by region, including Japan, Americas, China, Asia, and Europe, Middle East, and Africa. Eisai also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived by its Japanese pharmaceutical business, followed by its Americas pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.